Indivior Inc.

This study tested a new injectable medication called INDV-6001 in 123 adults with moderate to severe opioid use disorder. The goal was to see how the drug moves through the body, if it is safe, and how well people tolerate it. Participants received multiple doses, and researchers…

This study tested two different doses (100 mg vs 300 mg) of a monthly buprenorphine injection in 785 adults with moderate to severe opioid use disorder. The goal was to see which dose helped people stay in treatment and reduce opioid use. The study also compared a faster versus s…

This study tested a new drug called INDV-2000 in 300 adults with moderate to severe opioid use disorder who wanted to stop using opioids. Participants were randomly assigned to receive different doses of INDV-2000 or a placebo for 3 months. The main goal was to see if the drug co…

This completed study followed 480 adults with opioid use disorder who were already taking SUBLOCADE, a long-acting buprenorphine injection. Researchers observed participants for up to 4 years to see if they achieved remission, reduced opioid misuse, and improved their physical, m…

This completed study looked at 12 people with opioid use disorder who had been stable on SUBLOCADE injections for at least 9 months. Researchers wanted to see if they could successfully stop the medication without relapsing or restarting long-term treatment. The goal was to under…